Epithalon

Batch-specific analytical results are reported in the corresponding Certificate of Analysis. Identity, purity, and measured peptide content should be assessed according to the tests and results explicitly listed for that batch.

Published analytical documentation can be reviewed through the
Vertex Labs COA database.
Additional information regarding documentation standards and quality review is available on our
Testing Standards page.

Epithalon is identified by its four-residue sequence, Ala-Glu-Asp-Gly (AEDG), and associated molecular characteristics. The sequence describes the amino-acid order from the N-terminus to the C-terminus.

The molecular formula and molecular weight listed above describe the peptide without counterions. Any batch-specific salt form, counterion content, or other compositional details should be established from the corresponding analytical documentation.

Product identification includes the Epithalon name, labeled 10 mg fill amount, vial labeling, and batch number. The labeled fill amount and any measured peptide content are separate entries and should be distinguished in batch records.

Epithalon 10 mg is supplied as lyophilized powder in a sealed vial. The product is supplied without prior reconstitution.

Storage conditions are specified on the product label. Retain the original labeling and corresponding batch documentation for material traceability.